首页> 外文期刊>Archives of virology >Inhibition of hepatitis B virus replication by shRNAs in stably HBV expressed HEPG2 2.2.15 cell lines.
【24h】

Inhibition of hepatitis B virus replication by shRNAs in stably HBV expressed HEPG2 2.2.15 cell lines.

机译:shRNA在稳定的HBV表达的HEPG2 2.2.15细胞系中通过shRNA抑制乙型肝炎病毒复制。

获取原文
获取原文并翻译 | 示例
           

摘要

In this study, the effect of RNAi on HBV replication was observed in a cell culture model, HepG2 2.2.15 cell line, which supports human HBV ayw replication and expression. Aim of the study was to investigate effects of shRNAs (small hairpin RNAs) targeting hepatitis B virus mRNAs on the viral replication in HepG2 2.2.15 cells. We selected three target HBV mRNA regions with different putative secondary structures to test whether the secondary structure of RNA may affect the inhibition efficacy on the target HBV RNA. Three HBV-specific siRNAs (small interfering RNA) were designed targeting X (1689-1708), Core (2229-2248) and S (765-784 nt) transcripts. HepG2 2.2.15 cells were transfected with shRNA expressing plasmids, P765, P2229 and P1689 targeting S, core and X region, respectively or a mock plasmid targeting lacZ gene. The culture media was collected throughout six days after transfection and analyzed by real-time PCR. Viral DNA production was suppressed for 7 days. The HBV DNA levels were decreased by 73, 72 and 79% with P765, P2229 and P1689 vectors, respectively.In conclusion, the shRNAs designed for X, core and S regions, specifically and significantly suppressed HBV DNA. siRNAs potentially may be used in treatment of hepatitis B.
机译:在这项研究中,在支持人类HBV ayw复制和表达的细胞培养模型HepG2 2.2.15细胞系中观察到RNAi对HBV复制的影响。该研究的目的是研究靶向乙型肝炎病毒mRNA的shRNA(小发夹RNA)对HepG2 2.2.15细胞中病毒复制的影响。我们选择了具有不同推定二级结构的三个目标HBV mRNA区,以测试RNA的二级结构是否会影响对目标HBV RNA的抑制效果。设计了三种针对X(1689-1708),核心(2229-2248)和S(765-784 nt)转录本的HBV特异性siRNA(小干扰RNA)。用分别靶向S,核心和X区的shRNA表达质粒P765,P2229和P1689或靶向lacZ基因的模拟质粒转染HepG2 2.2.15细胞。转染后整整六天收集培养基,并通过实时PCR分析。病毒DNA的产生被抑制了7天。 P765,P2229和P1689载体分别使HBV DNA水平降低了73%,72%和79%。总而言之,针对X,核心和S区设计的shRNA特异且显着抑制了HBV DNA。 siRNA可能会用于治疗乙型肝炎。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号